Search - tctmd.com

Displaying 181 - 200 of 217

Sort: Relevancy | Date

Presentation TCT 2014

DCB in BMS vs DES ISR: Insights from the RIBS Trials

Presenter: Run-Lin Gao, Jochen Wöhrle, Bruno Scheller, Fernando Alfonso

September 13, 2014

News Conference News TCT 2014

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

Yael L. Maxwell

September 13, 2014

Presentation TCT 2013

RIBS IV-ISR Trial: Background and Trial Design

Presenter: Fernando Alfonso

October 31, 2013

Presentation TCT 2013

PEPCAD-China ISR Trial: 9-Month Angiographic and 1-Year Clinical Results

Presenter: Junbo Ge

October 31, 2013

Presentation TCT 2013

Critical Review of Drug-Coated Balloon Data for the Coronary ISR Application

Presenter: Bruno Scheller

October 31, 2013

Presentation TCT 2013

Angiosculpt DCB-ISR Trial

Presenter: Alexandre Abizaid

October 31, 2013

News Conference News TCT 2013

Drug-coated Balloons May Become Standard of Care in ISR

October 31, 2013

News Conference News TCT 2013

TCT Leadership Outlines the State of Intervention

October 30, 2013

News Conference News TCT 2013

Futuristic 3D Holography May Revolutionize Cardiac Procedures

October 30, 2013

Presentation TCT 2013

TCT-56. PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis ...

Presenter: Bo Xu

October 29, 2013

Presentation TCT 2013

The Valve Medical TAVR System (Israel)

Presenter: Martin Leon

October 28, 2013

Presentation TCT 2013

The Impact Of First- versus Second-Generation Drug-Eluting Stents On Immediate- and Intermediate-Term Outcomes In A Complex ST-Segment Elevation Myocardial Infarction Population

Presenter: Joshua Loh, Hironori Kitabata, Israel Barbash, Danny Dvir, Salem Badr, Rebecca Torguson, Kenneth Kent, Lowell Satler, William Suddath, Augusto Pichard, Ron Waksman

January 31, 2013

Presentation TCT 2013

Efficacy and Safety of Drug-Eluting Balloon Compared to Drug-Eluting Stent for The Treatment of In-Stent Restenosis (ISR)

Presenter: Myung-Hyun Kim, Byeong-Keuk Kim

January 31, 2013

Presentation TCT 2013

The Impact Of Upstream Anticoagulation On In-Hospital Bleeding In Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Presenter: Joshua Loh, Hironori Kitabata, Israel Barbash, Danny Dvir, Salem Badr, Rebecca Torguson, Kenneth Kent, Lowell Satler, William Suddath, Augusto Pichard, Ron Waksman

January 31, 2013

Presentation TCT 2013

Percutaneous Coronary Intervention In A Complex Patient Population: A Comparison of First- versus Second-Generation Drug-Eluting Stent Use On In-Hospital and 1-Year Outcomes

Presenter: Joshua Loh, Hironori Kitabata, Israel Barbash, Danny Dvir, Salem Badr, Rebecca Torguson, Kenneth Kent, Lowell Satler, William Suddath, Augusto Pichard, Ron Waksman

January 31, 2013

Presentation TCT 2013

Impact Of Clinical Presentation On In-Hospital Bleeding Outcomes In Percutaneous Coronary Intervention

Presenter: Joshua Loh, Hironori Kitabata, Israel Barbash, Danny Dvir, Salem Badr, Rebecca Torguson, Kenneth Kent, Lowell Satler, William Suddath, Augusto Pichard, Ron Waksman

January 31, 2013

Presentation TCT 2013

Comparison Of Long-term Outcomes With Everolimus-Eluting- and Sirolimus-Eluting Stents In Small Coronary Artery Disease

Presenter: Hironori Kitabata, Joshua Loh, Gabriel Sardi, Salem Badr, Danny Dvir, Israel Barbash, Rebecca Torguson, Kenneth Kent, Lowell Satler, William Suddath, Augusto Pichard, Ron Waksman

January 31, 2013

News Conference News TCT 2012

Mitral Valve-in-Valve Improves Outcomes in High-Risk Patients

October 29, 2012

Presentation TCT 2012

Case 2: Management of DES ISR with Drug Eluting Balloons

Presenter: Andrzej Ochala

October 26, 2012

Presentation TCT 2012

Case 1: Management of Focal DES ISR

Presenter: Ioannis Iakovou

October 26, 2012

Advertisement

DCB in BMS vs DES ISR: Insights from the RIBS Trials

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

RIBS IV-ISR Trial: Background and Trial Design

PEPCAD-China ISR Trial: 9-Month Angiographic and 1-Year Clinical Results

Critical Review of Drug-Coated Balloon Data for the Coronary ISR Application

Angiosculpt DCB-ISR Trial

Drug-coated Balloons May Become Standard of Care in ISR

TCT Leadership Outlines the State of Intervention

Futuristic 3D Holography May Revolutionize Cardiac Procedures

TCT-56. PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis ...

The Valve Medical TAVR System (Israel)

The Impact Of First- versus Second-Generation Drug-Eluting Stents On Immediate- and Intermediate-Term Outcomes In A Complex ST-Segment Elevation Myocardial Infarction Population

Efficacy and Safety of Drug-Eluting Balloon Compared to Drug-Eluting Stent for The Treatment of In-Stent Restenosis (ISR)

The Impact Of Upstream Anticoagulation On In-Hospital Bleeding In Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Percutaneous Coronary Intervention In A Complex Patient Population: A Comparison of First- versus Second-Generation Drug-Eluting Stent Use On In-Hospital and 1-Year Outcomes

Impact Of Clinical Presentation On In-Hospital Bleeding Outcomes In Percutaneous Coronary Intervention

Comparison Of Long-term Outcomes With Everolimus-Eluting- and Sirolimus-Eluting Stents In Small Coronary Artery Disease

Mitral Valve-in-Valve Improves Outcomes in High-Risk Patients

Case 2: Management of DES ISR with Drug Eluting Balloons

Case 1: Management of Focal DES ISR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content